Medications

Metformin inhibited C. diff spread in three study models

Researchers from Wake Forest School of Medicine in North Carolina have demonstrated that a common diabetes drug inhibits the spread of Clostridioides difficile, or C. diff—a potentially life-threatening infection commonly ...

Medical research

Study paves the way for preventing sudden cardiac arrest

A study comparing commonly used medications for type 2 diabetes has found that sulfonylurea drugs are associated with a reduced risk of out-of-hospital cardiac arrest compared with metformin. The research is published today ...

Medications

Treating aggressive breast cancer with an anti-diabetic drug

National University of Singapore researchers developed an approach to target highly resistant triple-negative breast cancers (TNBCs) by interfering with their energy production using cytotoxic gold-metformin prodrugs.

Medications

Diabetes drug shows potential in fighting cancer

The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents ...

Diseases, Conditions, Syndromes

Study finds metformin reduced COVID-19 death risks in women

University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of ...

page 9 from 31